CALCULATE YOUR SIP RETURNS

Shares That Hit Circuit Limits On February 25, 2025, Thangamayil Jewellery, Vijaya Diagnostic Centre and More

Written by: Dev SethiaUpdated on: Feb 25, 2025, 3:59 PM IST
On February 25, 2025, Sensex rose 0.20% to 74,602.12, while Nifty50 dipped 0.03% to 22,547.55, with stocks like Thangamayil Jewellery and E2E Networks hitting circuit limits.
Shares That Hit Circuit Limits On February 25, 2025, Thangamayil Jewellery, Vijaya Diagnostic Centre and More
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

On February 25, 2025, BSE Sensex closed 0.20% higher at 74,602.12, while Nifty50 fell 0.03% to 22,547.55. Amidst the market volatility, stocks like Thangamayil Jewellery, E2E Networks and Indo Vijaya Diagnostic Centre hit circuit limits, reflecting significant price movements. Check out the full list of stocks hitting circuits today.

Stocks That Hit Upper Circuit on February 25, 2025

Symbol LTP %chng Price Band % Volume(Lakhs) Value(₹ Crores)
Vijaya Diagnostic Centre 1,053.20 14.07 20 64.71 664.84
Godfrey Phillips India 5,667.75 1.46 5 4.76 275.34
Thangamayil Jewellery 1,863.05 20 20 2.69 47.93
Avalon Technologies 697.5 3.85 5 6.52 45.63
Blue Jet Healthcare 795 4.46 5 3.93 31.16

Stocks That Hit Lower Circuit on February 25, 2025

Symbol LTP %chng Price Band % Volume(Lakhs) Value(₹ Crores)
E2E Networks 1,980.20 -5 5 1.14 23.15
Deccan Cements 838 -6.74 10 1.65 13.9
Trident Techlabs 803.95 -5 5 0.66 5.32
Unitech 6.88 -4.44 5 61.67 4.3
Sahana Systems 1,374.00 -3.31 5 0.12 1.61

Overview of Companies Hitting Circuits Today

  • Thangamayil Jewellery

On February 25, 2025, Thangamayil Jewellery share price ended 20% higher at ₹1,861.85. Thangamayil Jewellery’s share price reached a 52-week high of ₹2,558.06, and a 52-week low of ₹1,107.62. At the current price, Thangamayil Jewellery shares are trading at a price-to-earnings (P/E) ratio of 44.21x, based on its trailing 12-month earnings per share (EPS) of ₹42.11, and a price-to-book (P/B) ratio of 9.90, according to exchange data.

  • Vijaya Diagnostic Centre

On February 25, 2025, Vijaya Diagnostic Centre share price ended 13.99% higher at ₹1052.50. Vijaya Diagnostic Centre’s share price reached a 52-week high of ₹1,276.75, and a 52-week low of ₹596.05. At the current price, Vijaya Diagnostic Centre shares are trading at a price-to-earnings (P/E) ratio of 81.59x, based on its trailing 12-month earnings per share (EPS) of ₹12.90, and a price-to-book (P/B) ratio of 15.09, according to exchange data.

  • E2E Networks

On February 25, 2025, E2E Networks share price ended 5% lower at ₹1,980.20. E2E Networks’ share price reached a 52-week high of ₹5,487.65, and a 52-week low of ₹780.35. At the current price, E2E Networks shares are trading at a price-to-earnings (P/E) ratio of 111.17x, based on its trailing 12-month earnings per share (EPS) of ₹22.47, and a price-to-book (P/B) ratio of 2.68, according to exchange data.

  • Deccan Cements

On February 25, 2025, Deccan Cements share price ended 7.03% lower at ₹833.25. Deccan Cements’s share price reached a 52-week high of ₹925.70 and a 52-week low of ₹525.60. At the current price, Deccan Cements shares are trading at a price-to-earnings (P/E) ratio of 450.41x, based on its trailing 12-month earnings per share (EPS) of ₹1.85, and a price-to-book (P/B) ratio of 1.64, according to exchange data.

  • Blue Jet Healthcare

On February 25, 2025, Blue Jet Healthcare share price ended 3.95% higher at ₹797.85. Blue Jet Healthcare’s share price reached a 52-week high of ₹844.85, and a 52-week low of ₹328.95. At the current price, Blue Jet Healthcare India shares are trading at a price-to-earnings (P/E) ratio of 58.97x, based on its trailing 12-month earnings per share (EPS) of ₹13.53, and a price-to-book (P/B) ratio of 14.98, according to exchange data.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: Feb 25, 2025, 3:59 PM IST

Dev Sethia

Dev is a content writer with over 2 years of experience at Business Today, Times of India, and Financial Express. He has also contributed stories in Hindi for BT Bazaar and Khalsa Bandhan News Paper. A journalism postgraduate from ACJ-Bloomberg, Dev enjoys spending his spare time on the cricket pitch.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3 Cr+ happy customers